Increased life expectancy as a result of non-hormonal targeted therapies for HER2 or hormone receptor positive metastatic breast cancer: A systematic review and meta-analysis

Elsevier, Cancer Treatment Reviews, (55), p. 16-25

Journal article published in 2017 by Rositsa G. Koleva-Kolarova, Monika P. Oktora, Annelies L. Robijn

, Marcel J. W. Greuter, Anna K. L. Reyners, Erik Buskens, Geertruida H. de Bock

This paper is available in a repository.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by